Sutton Wealth Advisors Inc. Sage Therapeutics, Inc. Transaction History

Sutton Wealth Advisors Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2023	SELL	$32.28 - $43.27 $0 - $0	0 Closed	0 $0
Q2 2022 Nov 07, 2023	SELL	$27.52 - $37.99 $81,982 - $113,172	-2,979 Closed	0 $0
Q1 2022 Nov 07, 2023	SELL	$30.71 - $45.71 $25,520 - $37,985	-831 Reduced 21.81%	2,979 $98.6 Million
Q2 2020 Nov 07, 2023	BUY	$25.95 - $43.15 $89,112 - $148,177	3,434 Added 913.3%	3,810 $158 Million
Q1 2020 Nov 07, 2023	BUY	$26.15 - $77.24 $9,832 - $29,042	376 New	376 $10.8 Million
Q3 2018 Nov 06, 2023	SELL	$138.11 - $169.04 $8,700 - $10,649	-63 Closed	0 $0
Q2 2018 Nov 06, 2023	BUY	$140.36 - $175.76 $8,842 - $11,072	63 New	63 $9.86 Million

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.